Short answer
LEMAITRE VASCULAR INC (LMAT) filed its Q1 2026 10-Q quarterly report on May 6, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $67M (up 11.2% year over year) with net income of $16M.
Q1 2026 key financials · XBRL
- Revenue
- $67M
- +11.2% YoY
- Net income
- $16M
- +42.4% YoY
- Operating margin
- 26.7%
- Gross margin
- 72.7%
- EPS (diluted)
- $0.68
- +41.7% YoY
Source: XBRL data from the LEMAITRE VASCULAR INC (LMAT) Q1 2026 10-Q on SEC EDGAR. USD.
LEMAITRE VASCULAR INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material changes to risk factors disclosed in the December 31, 2025 Form 10-K
- Carried-forward risks remain unchanged from the prior annual filing
- New $100.0 million share-repurchase authorization through February 18, 2027
- CEO Rule 10b5-1 arrangement covering up to 200,000 shares through March 10, 2028
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other LEMAITRE VASCULAR INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.